StockWatch
·

Inhibrx Biosciences, Inc.

Ticker: 2007919

P/L Snapshot

Q3 FY26 · consolidated

vs Q2 FY25
Revenue
2.00
+53.8%
Expenditure
33.74
+17.6%
Net Profit
-38.73
-35.2%
OPM %
-100.00%

Shareholding

Pattern breakdown

P/L Trends

(in millions)

RevenueExpenditureNet Profit
-280.97311.07903.111.5K2.1KQ3 FY23Q2 FY24Q2 FY25Q3 FY26
Price Chart
Latest News